Cargando…
Serological surveys to inform SARS-CoV-2 epidemic curve: a cross-sectional study from Odisha, India
This was a population based cross-sectional study carried out to estimate and compare the seroprevalence, hidden prevalence and determine the demographic risk factors associated with SARS-CoV-2 infection among adults in the three largest cities of Odisha, India, and ascertain the association with th...
Autores principales: | , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8131641/ https://www.ncbi.nlm.nih.gov/pubmed/34006960 http://dx.doi.org/10.1038/s41598-021-89877-y |
_version_ | 1783694742289121280 |
---|---|
author | Kshatri, Jaya Singh Bhattacharya, Debdutta Kanungo, Srikanta Giri, Sidhartha Palo, Subrata Kumar Parai, Debaprasad Turuk, Jyotirmayee Mansingh, Asit Choudhary, Hari Ram Pattnaik, Matrujyoti Dash, Girish Chandra Mohanty, Prasantajyoti Mishra, Niranjan Satapathy, Durga Madhab Sahoo, Sanjaya Kumar Pati, Sanghamitra |
author_facet | Kshatri, Jaya Singh Bhattacharya, Debdutta Kanungo, Srikanta Giri, Sidhartha Palo, Subrata Kumar Parai, Debaprasad Turuk, Jyotirmayee Mansingh, Asit Choudhary, Hari Ram Pattnaik, Matrujyoti Dash, Girish Chandra Mohanty, Prasantajyoti Mishra, Niranjan Satapathy, Durga Madhab Sahoo, Sanjaya Kumar Pati, Sanghamitra |
author_sort | Kshatri, Jaya Singh |
collection | PubMed |
description | This was a population based cross-sectional study carried out to estimate and compare the seroprevalence, hidden prevalence and determine the demographic risk factors associated with SARS-CoV-2 infection among adults in the three largest cities of Odisha, India, and ascertain the association with the progression of the epidemic. The survey carried out in August 2020 in the three largest cities of the state of Odisha, India. Blood samples were collected from the residents using random sampling methods and tested for anti- SARS CoV-2 antibodies using an automated CLIA platform. A total of 4146 participants from the 3 cities of Bhubaneswar (BBS), Berhampur (BAM) and Rourkela (RKL) participated. The female to male participation ratio was 5.9:10 across the three cities. The gender weighted seroprevalence across the three cities was 20.78% (95% CI 19.56–22.05%). While females reported a higher seroprevalence (22.8%) as compared to males (18.8%), there was no significant difference in seroprevalence across age groups. A majority of the seropositive participants were asymptomatic (90.49%). The case to infection ratio on the date of serosurvey was 1:6.6 in BBS, 1:61 in BAM and 1:29.8 in RKL. The study found a high seroprevalence against COVID-19 in urban Odisha as well as high numbers of asymptomatic infections. The epidemic curves had a correlation with the seroprevalence. |
format | Online Article Text |
id | pubmed-8131641 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-81316412021-05-25 Serological surveys to inform SARS-CoV-2 epidemic curve: a cross-sectional study from Odisha, India Kshatri, Jaya Singh Bhattacharya, Debdutta Kanungo, Srikanta Giri, Sidhartha Palo, Subrata Kumar Parai, Debaprasad Turuk, Jyotirmayee Mansingh, Asit Choudhary, Hari Ram Pattnaik, Matrujyoti Dash, Girish Chandra Mohanty, Prasantajyoti Mishra, Niranjan Satapathy, Durga Madhab Sahoo, Sanjaya Kumar Pati, Sanghamitra Sci Rep Article This was a population based cross-sectional study carried out to estimate and compare the seroprevalence, hidden prevalence and determine the demographic risk factors associated with SARS-CoV-2 infection among adults in the three largest cities of Odisha, India, and ascertain the association with the progression of the epidemic. The survey carried out in August 2020 in the three largest cities of the state of Odisha, India. Blood samples were collected from the residents using random sampling methods and tested for anti- SARS CoV-2 antibodies using an automated CLIA platform. A total of 4146 participants from the 3 cities of Bhubaneswar (BBS), Berhampur (BAM) and Rourkela (RKL) participated. The female to male participation ratio was 5.9:10 across the three cities. The gender weighted seroprevalence across the three cities was 20.78% (95% CI 19.56–22.05%). While females reported a higher seroprevalence (22.8%) as compared to males (18.8%), there was no significant difference in seroprevalence across age groups. A majority of the seropositive participants were asymptomatic (90.49%). The case to infection ratio on the date of serosurvey was 1:6.6 in BBS, 1:61 in BAM and 1:29.8 in RKL. The study found a high seroprevalence against COVID-19 in urban Odisha as well as high numbers of asymptomatic infections. The epidemic curves had a correlation with the seroprevalence. Nature Publishing Group UK 2021-05-18 /pmc/articles/PMC8131641/ /pubmed/34006960 http://dx.doi.org/10.1038/s41598-021-89877-y Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Article Kshatri, Jaya Singh Bhattacharya, Debdutta Kanungo, Srikanta Giri, Sidhartha Palo, Subrata Kumar Parai, Debaprasad Turuk, Jyotirmayee Mansingh, Asit Choudhary, Hari Ram Pattnaik, Matrujyoti Dash, Girish Chandra Mohanty, Prasantajyoti Mishra, Niranjan Satapathy, Durga Madhab Sahoo, Sanjaya Kumar Pati, Sanghamitra Serological surveys to inform SARS-CoV-2 epidemic curve: a cross-sectional study from Odisha, India |
title | Serological surveys to inform SARS-CoV-2 epidemic curve: a cross-sectional study from Odisha, India |
title_full | Serological surveys to inform SARS-CoV-2 epidemic curve: a cross-sectional study from Odisha, India |
title_fullStr | Serological surveys to inform SARS-CoV-2 epidemic curve: a cross-sectional study from Odisha, India |
title_full_unstemmed | Serological surveys to inform SARS-CoV-2 epidemic curve: a cross-sectional study from Odisha, India |
title_short | Serological surveys to inform SARS-CoV-2 epidemic curve: a cross-sectional study from Odisha, India |
title_sort | serological surveys to inform sars-cov-2 epidemic curve: a cross-sectional study from odisha, india |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8131641/ https://www.ncbi.nlm.nih.gov/pubmed/34006960 http://dx.doi.org/10.1038/s41598-021-89877-y |
work_keys_str_mv | AT kshatrijayasingh serologicalsurveystoinformsarscov2epidemiccurveacrosssectionalstudyfromodishaindia AT bhattacharyadebdutta serologicalsurveystoinformsarscov2epidemiccurveacrosssectionalstudyfromodishaindia AT kanungosrikanta serologicalsurveystoinformsarscov2epidemiccurveacrosssectionalstudyfromodishaindia AT girisidhartha serologicalsurveystoinformsarscov2epidemiccurveacrosssectionalstudyfromodishaindia AT palosubratakumar serologicalsurveystoinformsarscov2epidemiccurveacrosssectionalstudyfromodishaindia AT paraidebaprasad serologicalsurveystoinformsarscov2epidemiccurveacrosssectionalstudyfromodishaindia AT turukjyotirmayee serologicalsurveystoinformsarscov2epidemiccurveacrosssectionalstudyfromodishaindia AT mansinghasit serologicalsurveystoinformsarscov2epidemiccurveacrosssectionalstudyfromodishaindia AT choudharyhariram serologicalsurveystoinformsarscov2epidemiccurveacrosssectionalstudyfromodishaindia AT pattnaikmatrujyoti serologicalsurveystoinformsarscov2epidemiccurveacrosssectionalstudyfromodishaindia AT dashgirishchandra serologicalsurveystoinformsarscov2epidemiccurveacrosssectionalstudyfromodishaindia AT mohantyprasantajyoti serologicalsurveystoinformsarscov2epidemiccurveacrosssectionalstudyfromodishaindia AT mishraniranjan serologicalsurveystoinformsarscov2epidemiccurveacrosssectionalstudyfromodishaindia AT satapathydurgamadhab serologicalsurveystoinformsarscov2epidemiccurveacrosssectionalstudyfromodishaindia AT sahoosanjayakumar serologicalsurveystoinformsarscov2epidemiccurveacrosssectionalstudyfromodishaindia AT patisanghamitra serologicalsurveystoinformsarscov2epidemiccurveacrosssectionalstudyfromodishaindia AT serologicalsurveystoinformsarscov2epidemiccurveacrosssectionalstudyfromodishaindia |